The Goodwin Global M&A team advised HLTH, Inc. (“HLTH”) on the completion of its sale to Regent US Holdco, Inc. (“Hyve”).
HLTH is a leading global platform focused on healthcare innovation and transformation. Through industry-leading events, inspiring digital content, and mission-driven initiatives, HLTH fosters a marketplace for the health community, driving dialogue and advancing the development of a better health ecosystem. The annual HLTH US event, that took place from October 20-23 in Las Vegas, will bring together over 12,000 participants, including healthcare leaders such as providers, payers, investors, and government officials, including the First Lady of the United States, Dr. Jill Biden, amongst others.
The deal team was led by Larry Chu, Daniel Saposnik, Zoya Lozoya Holladay, Julia Chang, and Anna Setyaeva (M&A/Corporate), Ora Grinberg and Garrett Gaughan (Tax), Crescent Chasteen, Eric Graffeo, and Benjamin Kurrass (ECB), Saba Rais (UK ECB), Joel E. Lehrer (IP), Edward Holzwanger and Alastair Papworth (L&E), Jacqueline Klosek, Alex Intile and Jonathan Ng (Privacy), Jacob Osborn, Charles Li, Carrie Miller, and Katie Dee (Global Trade), Cecelia Lockner (RWI), Paul Jin, Simone Waterbury, and Charlie Stewart (Antitrust), Barry Z. Bazian (Bankruptcy), Kevin Grumberg, Hugh O'Sullivan and Anthony Shaheen (Debt), Albert Solecki (Litigation), Jessica Rothstein, Katharine Cummings, and Shaleena Alli-Rampersad (Trademark), Gartan Tracey and Carl Bradshaw (UK Corporate), Alyssa Fitzgerald (Tax-Exempt Organizations), Scott Zilora and Matthew Mancini (Financial Analysis), with invaluable support from Kathryn Georgian.